Sabin Vaccine Report - Sabin Vaccine Institute
... journals, and it antici- Research Center project to examine the On a tour of Beijing are participants in the Parasite Grant review of the pates the publication of genetic diversity of hookworm. With Chinese Medical Board of New York. From left, Zhu Xin Ping, Wang a number of manu- help from CMB fund ...
... journals, and it antici- Research Center project to examine the On a tour of Beijing are participants in the Parasite Grant review of the pates the publication of genetic diversity of hookworm. With Chinese Medical Board of New York. From left, Zhu Xin Ping, Wang a number of manu- help from CMB fund ...
Australian Immunisation Handbook
... The disease can involve almost any mucous membrane. Pharyngeal diphtheria, by far the commonest form of disease in the unimmunised, is characterised by an inflammatory exudate that forms a greyish or green membrane in the upper respiratory tract, which can cause acute severe respiratory obstruction. ...
... The disease can involve almost any mucous membrane. Pharyngeal diphtheria, by far the commonest form of disease in the unimmunised, is characterised by an inflammatory exudate that forms a greyish or green membrane in the upper respiratory tract, which can cause acute severe respiratory obstruction. ...
WHO information sheet - World Health Organization
... and hepatitis B vaccination is difficult because these conditions are rare, have a poorly understood pathogenesis, occur in the absence of hepatitis B vaccination and the onset of symptoms maybe reported weeks to months after vaccination has occurred. Guillain–Barré Syndrome (GBS) – The pathogenesis ...
... and hepatitis B vaccination is difficult because these conditions are rare, have a poorly understood pathogenesis, occur in the absence of hepatitis B vaccination and the onset of symptoms maybe reported weeks to months after vaccination has occurred. Guillain–Barré Syndrome (GBS) – The pathogenesis ...
Facts About Diphtheria for Adults - National Foundation for Infectious
... Diphtheria is an acute bacterial disease that usually affects the tonsils, throat, nose and/or skin. It is usually spread from person to person by breathing in droplets that contain diphtheria bacteria. These droplets are produced after an infected person has coughed, sneezed or even laughed. The di ...
... Diphtheria is an acute bacterial disease that usually affects the tonsils, throat, nose and/or skin. It is usually spread from person to person by breathing in droplets that contain diphtheria bacteria. These droplets are produced after an infected person has coughed, sneezed or even laughed. The di ...
3. vaccine efficacy - Academy of Medicine of Malaysia
... coverage for Malaysia was 99.97% for BCG, 95.3% for DPT (third dose), 95.4% for OPV (third dose), 88.4% for measles and 93.5% for hepatitis B (third dose) in 2000 (Ministry of Health Malaysia, 2002, level 1). The new recommended immunisation schedule is as illustrated in Table 2 ...
... coverage for Malaysia was 99.97% for BCG, 95.3% for DPT (third dose), 95.4% for OPV (third dose), 88.4% for measles and 93.5% for hepatitis B (third dose) in 2000 (Ministry of Health Malaysia, 2002, level 1). The new recommended immunisation schedule is as illustrated in Table 2 ...
Australian Immunisation Handbook
... BCG (bacille Calmette-Guérin) vaccine is a suspension of a live attenuated strain of M. bovis. Worldwide, there are many BCG vaccines available, but they are all derived from the strain propagated by the Institute Pasteur, which was first tested in humans in 1921.12 BCG vaccination probably has litt ...
... BCG (bacille Calmette-Guérin) vaccine is a suspension of a live attenuated strain of M. bovis. Worldwide, there are many BCG vaccines available, but they are all derived from the strain propagated by the Institute Pasteur, which was first tested in humans in 1921.12 BCG vaccination probably has litt ...
Principle of Vaccinology
... • Killed Vaccines: Viruses (hep. A, Salk polio) Bacteria (pertussis, ...
... • Killed Vaccines: Viruses (hep. A, Salk polio) Bacteria (pertussis, ...
Smallpox as a Biological Weapon
... Historically, the rapidity of smallpox transmission throughout the population was generally slower than for such diseases as measles or chickenpox. Patients spread smallpox primarily to household members and friends; large outbreaks in schools, for example, were uncommon. This finding was accounted ...
... Historically, the rapidity of smallpox transmission throughout the population was generally slower than for such diseases as measles or chickenpox. Patients spread smallpox primarily to household members and friends; large outbreaks in schools, for example, were uncommon. This finding was accounted ...
Combination Vaccines: Defining and Addressing Current Safety
... Combination vaccines have been in use for 150 years. Historical problems with vaccines, including intussusception after rotavirus vaccine, carrier suppression with tetanus toxoid conjugate vaccines, and decreased immunogenicity of some Haemophilus influenzae type b conjugate vaccines when mixed with ...
... Combination vaccines have been in use for 150 years. Historical problems with vaccines, including intussusception after rotavirus vaccine, carrier suppression with tetanus toxoid conjugate vaccines, and decreased immunogenicity of some Haemophilus influenzae type b conjugate vaccines when mixed with ...
PDF printable version of Appendix 4: Commonly asked questions
... routinely recommended, with the exception of specific recommendations for meningococcal B vaccine in infants <2 years of age (refer to 4.10 Meningococcal disease). However, if an infant, child or adult has a fever of >38.5°C following vaccination or has pain at the injection site, paracetamol can be ...
... routinely recommended, with the exception of specific recommendations for meningococcal B vaccine in infants <2 years of age (refer to 4.10 Meningococcal disease). However, if an infant, child or adult has a fever of >38.5°C following vaccination or has pain at the injection site, paracetamol can be ...
Product Monograph Template - Schedule D
... vaccine. In villages where more than 70% of estimated susceptible individuals were vaccinated, a dramatic drop in the number of symptomatic cases of disease was observed within 8 weeks of vaccination. The mean titre of anti-HAV antibodies induced by HAVRIX® is at least 3 times higher than the maximu ...
... vaccine. In villages where more than 70% of estimated susceptible individuals were vaccinated, a dramatic drop in the number of symptomatic cases of disease was observed within 8 weeks of vaccination. The mean titre of anti-HAV antibodies induced by HAVRIX® is at least 3 times higher than the maximu ...
Contraindications and Precautionary Conditions for Vaccination
... BCG vaccine may be given concurrently with another live vaccine, but if they are not given at the same time, an interval of at least 3 weeks should be allowed between the administration of BCG vaccine and any other live vaccine, whichever is given first. No further immunization should be given for a ...
... BCG vaccine may be given concurrently with another live vaccine, but if they are not given at the same time, an interval of at least 3 weeks should be allowed between the administration of BCG vaccine and any other live vaccine, whichever is given first. No further immunization should be given for a ...
Classification of Vaccines
... Conventional vaccines have been based on live attenuated pathogens, and contain laboratory-weakened versions of the original pathogen. The rationale for using live attenuated vaccines is that they mimic the natural infection, which results in an effective vaccination strategy. The advantage of this ...
... Conventional vaccines have been based on live attenuated pathogens, and contain laboratory-weakened versions of the original pathogen. The rationale for using live attenuated vaccines is that they mimic the natural infection, which results in an effective vaccination strategy. The advantage of this ...
Read Chapter 1 - MedFoxPub.com
... strategy is not without significant health risks. In addition, many viruses, such as those causing influenza, can evolve into new strains that are unaffected by the antibodies that were developed in response to a previous vaccination. For example, this year’s flu vaccination — which was created fro ...
... strategy is not without significant health risks. In addition, many viruses, such as those causing influenza, can evolve into new strains that are unaffected by the antibodies that were developed in response to a previous vaccination. For example, this year’s flu vaccination — which was created fro ...
Untitled - Natural Health 365
... strategy is not without significant health risks. In addition, many viruses, such as those causing influenza, can evolve into new strains that are unaffected by the antibodies that were developed in response to a previous vaccination. For example, this year’s flu vaccination — which was created fro ...
... strategy is not without significant health risks. In addition, many viruses, such as those causing influenza, can evolve into new strains that are unaffected by the antibodies that were developed in response to a previous vaccination. For example, this year’s flu vaccination — which was created fro ...
Infectious Disease Prevention HOT TOPICS
... appropriately to vaccination; modified-live vaccines occasionally induce the disease in these animals. If high levels of specific antibodies are present, vaccine efficacy is diminished. This is a particularly important consideration when vaccinating puppies or kittens from well-vaccinated dams. Dise ...
... appropriately to vaccination; modified-live vaccines occasionally induce the disease in these animals. If high levels of specific antibodies are present, vaccine efficacy is diminished. This is a particularly important consideration when vaccinating puppies or kittens from well-vaccinated dams. Dise ...
Low hepatitis B immunogenicity of a hexavalent vaccine widely used
... groups were similar in terms of sex, age, time since completion of vaccination and birth weight (Table 1). The only vaccines administered concomitantly with Hexavac or Infanrix hexa were MMR (Hexavac, n=12 ; Infanrix hexa, n=16) and pneumococcal vaccine (Hexavac, n=6; Infanrix hexa, n=1). No child w ...
... groups were similar in terms of sex, age, time since completion of vaccination and birth weight (Table 1). The only vaccines administered concomitantly with Hexavac or Infanrix hexa were MMR (Hexavac, n=12 ; Infanrix hexa, n=16) and pneumococcal vaccine (Hexavac, n=6; Infanrix hexa, n=1). No child w ...
Considerations for Combination Vaccine Development and Use in
... vaccine that includes DTP, Hep B, and Hib is now available. Many countries have rapidly adopted this combination, because it facilitates the introduction of 2 new vaccines (Hep B and Hib) simultaneously into the immunization program. This has been the case for Mexico, Nicaragua, Bolivia, Guyana, and ...
... vaccine that includes DTP, Hep B, and Hib is now available. Many countries have rapidly adopted this combination, because it facilitates the introduction of 2 new vaccines (Hep B and Hib) simultaneously into the immunization program. This has been the case for Mexico, Nicaragua, Bolivia, Guyana, and ...
Rapid Emergence of Free-Riding Behavior in New Pediatric
... modelling has been devoted to the question of how vaccinating behavior evolves in the first years of a free, universal immunization program, where vaccines for a pediatric infectious disease are offered for free at a specified age. While the first few birth cohorts may choose to vaccinate at high ra ...
... modelling has been devoted to the question of how vaccinating behavior evolves in the first years of a free, universal immunization program, where vaccines for a pediatric infectious disease are offered for free at a specified age. While the first few birth cohorts may choose to vaccinate at high ra ...
Pertussis (Whooping cough)
... 15. Le T, Cherry JA, Chang S, Knoll Maria D, Lee MartinA L, Barenkamp S, et al. Immune Responses and Antibody Decay after Immunization of Adolescents and Adults with an Acellular Pertussis Vaccine: The APERT Study. The Journal of Infectious Diseases. 2004;190(3):535-44. 16. Versteegh FGA, Mertens PL ...
... 15. Le T, Cherry JA, Chang S, Knoll Maria D, Lee MartinA L, Barenkamp S, et al. Immune Responses and Antibody Decay after Immunization of Adolescents and Adults with an Acellular Pertussis Vaccine: The APERT Study. The Journal of Infectious Diseases. 2004;190(3):535-44. 16. Versteegh FGA, Mertens PL ...
All Vaccines Are Dangerous
... the risk of multiple sclerosis in the longer term.9 In testimony before Congress in 1999, Dr. Jane Orient read a statement on behalf of the Association of American Physicians and Surgeons in which she stated: "For most children, the risk of a serious vaccine reaction may be 100 times greater than th ...
... the risk of multiple sclerosis in the longer term.9 In testimony before Congress in 1999, Dr. Jane Orient read a statement on behalf of the Association of American Physicians and Surgeons in which she stated: "For most children, the risk of a serious vaccine reaction may be 100 times greater than th ...
ORGANIC OUTREACH
... • Documented administration of two doses of live measles virus vaccine on or after the first birthday and at least 28 days apart; or • Laboratory evidence of immunity or laboratory confirmation of disease; or • Birth before 1957* Documentation of physician-diagnosed measles is no longer acceptable e ...
... • Documented administration of two doses of live measles virus vaccine on or after the first birthday and at least 28 days apart; or • Laboratory evidence of immunity or laboratory confirmation of disease; or • Birth before 1957* Documentation of physician-diagnosed measles is no longer acceptable e ...
European Society for Paediatric Infectious Diseases/European
... {{Centre of Paediatrics, Vilnius University, Vilnius, Lithuania Vaccine ...
... {{Centre of Paediatrics, Vilnius University, Vilnius, Lithuania Vaccine ...
Measles - Government of Nova Scotia
... In Nova Scotia the following groups are eligible to receive MMR vaccine as part of the publically funded immunization program. 1. Infants and Children: • Two doses of a measles-containing vaccine are recommended for children with the first dose provided at one year of age, and the second dose at ei ...
... In Nova Scotia the following groups are eligible to receive MMR vaccine as part of the publically funded immunization program. 1. Infants and Children: • Two doses of a measles-containing vaccine are recommended for children with the first dose provided at one year of age, and the second dose at ei ...
Chickenpox - Children`s Hospital of Philadelphia
... the head and spreads to the rest of the body, and itching. A typical person will have 300 to 500 blisters which appear in phases, so that not all blisters are at the same stage. Complications from chickenpox are more likely in teens, adults, infants younger than 1 year old, newborns whose mom develo ...
... the head and spreads to the rest of the body, and itching. A typical person will have 300 to 500 blisters which appear in phases, so that not all blisters are at the same stage. Complications from chickenpox are more likely in teens, adults, infants younger than 1 year old, newborns whose mom develo ...
Poliomyelitis
Poliomyelitis, often called polio or infantile paralysis, is an infectious disease caused by the poliovirus. Approximately 90% to 95% of infections cause no symptoms. Another 5 to 10% of people have minor symptoms such as: fever, headache, vomiting, diarrhea, neck stiffness and pains in the arms and legs. These people are usually back to normal within one or two weeks. In about 0.5% of cases there is muscle weakness resulting in an inability to move. This can occur over a few hours to few days. The weakness most often involves the legs but may less commonly involve the muscles of the head, neck and diaphragm. Many but not all people fully recover. In those with muscle weakness about 2% to 5% of children and 15% to 30% of adults die. Years after recovery post-polio syndrome may occur, with a slow development of muscle weakness similar to what the person had during the initial infection.Poliovirus is usually spread from person to person through infected feces entering the mouth. It may also be spread by food or water containing human feces and less commonly from infected saliva. Those who are infected may spread the disease even if no symptoms are present for up to six weeks. The disease may be diagnosed by finding the virus in the feces or detecting antibodies against it in the blood.The disease is preventable with the polio vaccine; however, a number of doses are required for it to be effective. The United States Center for Disease Control recommends polio vaccination boosters for travelers and those who live in countries where the disease is occurring. Once infected there is no specific treatment. In 2013 polio affected 416 people down from 350,000 cases in 1988. In 2014 the disease was only spreading between people in Afghanistan, Nigeria, and Pakistan. In 2015 wild polio was eliminated in Nigeria.Poliomyelitis has existed for thousands of years, with depictions of the disease in ancient art. The disease was first recognized as a distinct condition by Michael Underwood in 1789 and the virus that causes it was first identified in 1908 by Karl Landsteiner. Major outbreaks started to occur in the late 19th century in Europe and the United States. In the 20th century it became one of the most worrying childhood diseases in these areas. The first polio vaccine was developed in the 1950s by Jonas Salk. It is hoped that vaccination efforts and early detection of cases will result in global eradication of the disease by 2018. In 2013; however, there were reports of new cases in Syria and in May 2014, the World Health Organization declared a public health emergency of international concern due to outbreaks of the disease in Asia, Africa and the Middle East. The disease does not naturally occur in any other animals.